Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 2
- Exclusivities
- 1
- Countries
- 1
- Base
- Germany
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Aeterna Zentaris GmbH | Weism�llerstr. 50, Frankfurt, 60314, Germany (DEU) | Analytical testing | 3006524368331800032 |
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8192719 | MACRILENmacimorelin acetate | use | Oct 2027 |
| 8192719*PED | MACRILENmacimorelin acetate | use | Apr 2028 |
| Product | Exclusivity | Until |
|---|---|---|
| MACRILENMACIMORELIN ACETATE | PED Paediatric | Jan 2030 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Macrilen | Macimorelin acetate | granule, for solution, oral | 58844-130NDA |
Compare
Comparable companies in Germany
- Excella GmbH & Co. KG1 site · 73 NDC
- Rottendorf Pharma GmbH1 site · 17 NDC
- Heraeus Precious Metals GmbH Co KG1 site · 10 NDC
- Solupharm Pharmazeutische Erzeugnisse GmbH1 site · 10 NDC
- CU Chemie Uetikon GmbH1 site · 9 NDC
- Chemcon GmbH1 site · 7 NDC
- Fidelio Healthcare Limburg GmbH1 site · 6 NDC
- LYOCONTRACT GmbH1 site · 6 NDC
- Wasserburger Arzneimittelwerk GmbH1 site · 4 NDC
- Dynamit Nobel GmbH Explosivstoff- und Systemtechnik1 site · 3 NDC
Enquiry
Common questions
- Is Aeterna Zentaris GmbH FDA approved?
- Aeterna Zentaris GmbH holds 1 FDA-registered establishment in Germany. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Aeterna Zentaris GmbH's registered sites?
- The FDA register lists Frankfurt. Registered operations: analytical testing.
- What drugs does Aeterna Zentaris GmbH make?
- 1 product is listed under Aeterna Zentaris GmbH in the openFDA NDC Directory, most often as granule, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.